GuidelineAtencion primaria2026
[SEIOMM-SEMERGEN-semFYC-SEMG recommendations for the management of patients with osteoporosis/fragility fracture in primary care].
Guideline in Atencion primaria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis is characterized by decreased bone mineral density and deterioration of bone microarchitecture, leading to increased skeletal vulnerability and susceptibility to fracture. These fractures impose a substantial clinical, social, and economic burden, significantly elevating morbidity and mortality. However, a relevant gap persists in diagnosis and therapeutic management, particularly within primary care. This document presents the first consensus recommendations developed by four scientific societies (SEIOMM, SEMERGEN, semFYC, and SEMG), derived from a Delphi process and supported by the most current scientific evidence. Its objective is to unify clinical criteria and improve coordination across healthcare levels. The recommendations are structured around: identification and assessment of fracture risk, treatment, follow-up, and referral criteria. The use of 10-year fracture risk assessment tools such as FRAX (Fracture Risk Assessment Tool) and dual-energy X-ray absorptiometry (DXA) is proposed for risk stratification, and clear guidelines are established for initiating treatment based on the patient's profile. The importance of treatment adherence, periodic reassessment, and patient participation in decision-making is emphasized.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.